Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans ...

The INMC analysis links pathological response after neoadjuvant immunotherapy with long-term outcomes in melanoma and ...

Doctors in Illinois and Michigan detailed a 46-year-old man with a previous history of skin cancer who bought the peptide Melanotan-II to help with his tanning. Five weeks after he started using the ...

Alex Shved took the province to court after OHIP rejected his oncologist's request to receive urgent treatment in the U.S.

The trip of a lifetime to the US to watch basketball has turned into a fight for life for a young Melbourne man after a ...

Volunteer Intake Remains Open as the Company Prepares to Post Updated Evaluation Results on Its Corporate Website in ...

Melanoma detection is rising, but mortality isn't. Are we catching more dangerous cancers or overlabeling harmless lesions?

The clinical director at CUH has strongly advocated for the post to be filled, but it is still awaiting national HSE approval ...

A family-based telehealth intervention improves sun-protective behaviors among children of melanoma survivors but did not ...

Exploring Chronic Toxicity After Adjuvant Anti-PD-1 for Melanoma / Andrea Boutros, cancer, JAMA Network Open, Melanoma, ...

A Victorian man facing the prospect of complete blindness after being diagnosed with ocular melanoma in his only seeing eye ...